Pain News and Research

Latest Pain News and Research

Winston announces Phase II study results of Dolorac for chronic migraine at Lazard Conference

Winston Pharmaceuticals, Inc. a specialty pharmaceutical company focused on developing and commercializing novel pain management therapies, announced the results of its Phase II study on its patented Dolorac Nasal Solution (doxepin 0.4%) for prophylaxis of chronic migraine at the Lazard Capital Markets 7th Annual Healthcare Conference in New York.

22 Nov 2010

UC San Diego designated as Blue Distinction Center

UC San Diego Health System has been designated as a Blue Distinction Center for Spine Surgery and a Blue Distinction Center for Knee and Hip Replacement. This honor is awarded to medical facilities that have demonstrated expertise in delivering quality health care in certain specialty medical areas by the Blue Cross and Blue Shield Association.

22 Nov 2010

FDA grants Impax tentative approval for generic Cymbalta NDA

Impax Laboratories, Inc. confirmed that the U.S. Food and Drug Administration (FDA) has granted tentative approval of the Company's Abbreviated New Drug Application for generic version of Cymbalta® delayed-release (duloxetine hydrochloride) 20, 30 and 60 mg capsules.

22 Nov 2010

Neurocrine announces results from elagolix Phase II Daisy PETAL study in endometriosis

Neurocrine Biosciences, Inc. today announced results from the open-label portion of the six month Phase II Daisy PETAL study (901 study) using its proprietary, orally-active nonpeptide Gonadotropin-Releasing Hormone (GnRH) receptor antagonist, elagolix, in patients with endometriosis.

22 Nov 2010

Convergence enters drug discovery collaboration with Selcia for chronic pain treatment

Convergence Pharmaceuticals Limited, the new company focused on the development of novel and high value analgesic medicines, and Selcia Limited, a contract research organisation, today are pleased to announce that they have entered into a drug discovery collaboration to identify and develop high quality candidate molecules for the treatment of chronic pain.

22 Nov 2010

VYTORIN reduces major vascular events in patients with chronic kidney disease

In a new investigational study of VYTORIN, the cholesterol-lowering medicine from Merck, VYTORIN 10/20 mg reduced the incidence of first major vascular events defined as non-fatal heart attacks or cardiac death, stroke or any revascularization procedure by a highly statistically significant 16.1 percent compared to placebo, Study of Heart and Renal Protection study involved more than 9,000 patients who, on average, had advanced or end-stage chronic kidney disease (CKD)

22 Nov 2010

Phase 3 study of VEGF Trap-Eye regimen meets primary endpoint in patients with wet AMD

Regeneron Pharmaceuticals, Inc. and Bayer HealthCare announced that in two parallel Phase 3 studies in patients with the neovascular form of age-related macular degeneration (wet AMD), all regimens of VEGF Trap-Eye (aflibercept ophthalmic solution), including VEGF Trap-Eye dosed every two months, successfully met the primary endpoint compared to the current standard of care, ranibizumab dosed every month.

22 Nov 2010

Assessment by nurse practitioner satisfies patients with back problems: Study

Ninety-six per cent of patients with back problems were satisfied with the assessment carried out by a specially trained nurse practitioner, according to a study in the December issue of the Journal of Advanced Nursing.

20 Nov 2010

Dr. Gupta interviewed for upcoming segment of World Progress Report

Dr. Sameer Gupta, of Vein Clinic PA, was recently interviewed for an upcoming segment of World Progress Report, hosted by Joan Lunden.

20 Nov 2010

Xanodyne to withdraw propoxyphene-containing products from the U.S. market

Xanodyne Pharmaceuticals, Inc. announced today that the company will voluntarily withdraw its Darvon, Darvon-N and Darvocet-N products from the U.S. market in consultation with the U.S. Food and Drug Administration (FDA).

20 Nov 2010

Simple strategies to cope with holiday stress

Dr. Richard Blonna, author, life coach, and stress management expert, offers five simple strategies for managing holiday stress. His approach to managing the worry and anxiety associated with holiday stress is adapted from his new book, Stress Less, Live More; How Acceptance and Commitment Therapy Can Help You Live a Busy Yet Balanced Life.

20 Nov 2010

BizVotes.com identifies Dr. Ryan Groelz as Best Chiropractor in Broomfield, Colorado

Dr. Ryan Groelz of Rock Creek Spine and Rehabilitation Center has been voted the 'Best Chiropractor in Broomfield, Colorado' by BizVotes.com. A popular consumer website, BizVotes.com helps communities identify the best local businesses through an online voting system. Rock Creek Spine and Rehabilitation Center is currently listed in the top choice for chiropractic care in Broomfield.

20 Nov 2010

Franklin ranked among top 10 hospitals in New York State for joint replacement

Franklin Hospital is ranked the best on Long Island for joint replacement outcomes and also is tops in Nassau County for its overall success in orthopedics and joint replacement, according to the latest national study by HealthGrades.

20 Nov 2010

Vascular Disease Foundation urges diabetic patients to be alert about P.A.D. signs

P.A.D. occurs when arteries in the legs become narrowed or clogged with fatty deposits, reducing blood flow to the legs. This can result in leg muscle pain when walking, disability, amputation, and poor quality of life. Blocked arteries found in people with P.A.D. can be a red flag that other arteries, including those in the heart and brain, may also be blocked - increasing the risk of a heart attack or stroke.

20 Nov 2010

Platelet Rich Plasma Therapy reduces pain and improves function in knee osteoarthritis patients

The first American study that positions Platelet Rich Plasma Therapy (PRP) as a viable means in managing knee osteoarthritis, appeared today in the December issue of the American Journal of Physical Medicine & Rehabilitation (AJPMR). The study, authored by Dr. Steven Sampson of the Orthohealing Center in Los Angeles, details the account of 14 patients with primary and secondary knee osteoarthritis receiving three platelet-rich plasma injections in the affected knee at 4-week intervals with one year follow up.

20 Nov 2010

Xanodyne Pharmaceuticals decides to voluntarily remove propoxyphene from the U.S. market

Xanodyne Pharmaceuticals Inc. which makes Darvon and Darvocet, the brand version of the prescription pain medication propoxyphene, has agreed to withdraw the medication from the U.S. market at the request of the U.S. Food and Drug Administration. The FDA has also informed the generic manufacturers of propoxyphene-containing products of Xanodyne's decision and requested that they voluntarily remove their products as well.

20 Nov 2010

CMS grants Qutenza J-code to NeurogesX

NeurogesX, Inc. a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced that the Centers for Medicare and Medicaid Services (CMS) has granted a unique, Level II Health Care Common Procedural Coding System (Level II HCPCS), commonly referred to as a J-code, for Qutenza (capsaicin) 8% patch.

19 Nov 2010

Xgeva receives FDA approval for prevention of SREs in patients with bone metastases

The U.S. Food and Drug Administration approved Xgeva (denosumab) on Thursday to help prevent skeletal-related events (SREs) in patients with cancer that has spread (metastasized) and damaged the bone. Skeletal-related events include bone fractures from cancer and bone pain requiring radiation.

19 Nov 2010

International businessman donates $50,000 for SCCO cancer study

International businessman and philanthropist Foster Friess has donated $50,000 to help launch a study of small cell carcinoma of the ovary (SCCO) by the Translational Genomics Research Institute (TGen) and the Van Andel Research Institute (VARI).

19 Nov 2010

ProvenCare to focus on potential problems in lung cancer patients

Northwestern Memorial Hospital is one of six national participants in a pilot study that will test whether operable lung cancer patients and their families have a smoother care experience and better outcomes by hardwiring data systems to reduce medical error and to reliably adhere to best practice standards.

19 Nov 2010

Pain News and Research

Latest Pain News and Research

Winston announces Phase II study results of Dolorac for chronic migraine at Lazard Conference

UC San Diego designated as Blue Distinction Center

FDA grants Impax tentative approval for generic Cymbalta NDA

Neurocrine announces results from elagolix Phase II Daisy PETAL study in endometriosis

Convergence enters drug discovery collaboration with Selcia for chronic pain treatment

VYTORIN reduces major vascular events in patients with chronic kidney disease

Phase 3 study of VEGF Trap-Eye regimen meets primary endpoint in patients with wet AMD

Assessment by nurse practitioner satisfies patients with back problems: Study

Dr. Gupta interviewed for upcoming segment of World Progress Report

Xanodyne to withdraw propoxyphene-containing products from the U.S. market

Simple strategies to cope with holiday stress

BizVotes.com identifies Dr. Ryan Groelz as Best Chiropractor in Broomfield, Colorado

Franklin ranked among top 10 hospitals in New York State for joint replacement

Vascular Disease Foundation urges diabetic patients to be alert about P.A.D. signs

Platelet Rich Plasma Therapy reduces pain and improves function in knee osteoarthritis patients

Xanodyne Pharmaceuticals decides to voluntarily remove propoxyphene from the U.S. market

CMS grants Qutenza J-code to NeurogesX

Xgeva receives FDA approval for prevention of SREs in patients with bone metastases

International businessman donates $50,000 for SCCO cancer study

ProvenCare to focus on potential problems in lung cancer patients

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Pain News and Research

Latest Pain News and Research

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Newsletters you may be interested in